Patent directory · USPTO A61K / A61P
Patents matching “Regents of the University of CA”
3,501 pharma patents match "Regents of the University of CA" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,501 pharmaceutical patents matching "Regents of the University of CA" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10434111
Compositions and methods for modification of biomolecules
granted -
US 10434069
Protease assisted native-protein delivery approach (PANDA)
granted -
US 10435355
Inhibitors of fatty acid amide hydrolase (FAAH) enzyme with improved oral bioavailability and their use as medicaments
granted -
US 10428352
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 10428143
Modulation of stimulatory and non-stimulatory myeloid cells
granted -
US 10428113
Compositions for expanding regulatory T cells (Treg), and treating autoimmune and inflammatory diseases and conditions
granted -
US 10426786
Mitigation of epileptic seizures by combination therapy using benzodiazepines and neurosteroids
granted -
US 10421980
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 10420918
Compositions and methods for reducing traumatic edema of the central nervous system
granted -
US 10422004
Diagnostic method for distinguishing forms of esophageal eosinophilia
granted -
US 10421722
Sulfur-containing compounds targeting vesicular acetylcholine transporter
granted -
US 10421773
Bone-selective osteogenic oxysterol bisphosphonate analogs
granted -
US 10415061
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 10413577
Compositions and methods for promoting growth of beneficial microbes to treat or prevent disease or prolong life
granted -
US 10406225
Anti-EphA2 antibodies and methods of use thereof
granted -
US 10406169
Methods of monitoring estriol therapy
granted -
US 10407697
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 10407503
Fully human antibodies and fragments recognizing human c-Met
granted -
US 10406233
Telodendrimers with enhanced drug delivery
granted -
US 10407374
Compositions and methods for ameliorating CNS inflammation, psychosis, delirium, PTSD or PTSS
granted -
US 10407488
Therapy for treatment or prevention of conditions associated with bleeding or hypocoagulation
granted -
US 10400253
Methods and compositions or RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 10400006
Estrogen receptor modulators
granted -
US 10400010
Structure-based peptide inhibitors of P53 aggregation as a new approach to cancer therapeutics
granted